Description:The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Dow Jones U.S. Select Pharmaceuticals Index (the "Underlying Index"). The Underlying Index measures the performance of the pharmaceuticals sector of the U.S. equity market. The Underlying Index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.
|JNJ||Johnson & Johnson||9.94%|
|MRK||Merck & Company||8.36%|
|BMY||Bristol-Myers Squibb Company||6.49%|
|LLY||Eli Lilly And Company||5.88%|
Data is provided by Zacks Investment Research